| A potent isoprenylcysteine carboxylmethyltransferase (ICMT) inhibitor improves survival in Ras-driven acute myeloid leukemia NI Marin-Ramos, M Balabasquer, FJ Ortega-Nogales, IR Torrecillas, ... Journal of medicinal chemistry, 2019 | 33 | 2019 |
| Myc-related mitochondrial activity as a novel target for multiple myeloma A Ortiz-Ruiz, Y Ruiz-Heredia, ML Morales, P Aguilar-Garrido, ... Cancers 13 (7), 1662, 2021 | 11 | 2021 |
| The Role of RNA-Binding Proteins in Hematological Malignancies P Aguilar-Garrido, A Otero-Sobrino, MÁ Navarro-Aguadero, ... International Journal of Molecular Sciences 23 (17), 9552, 2022 | 7 | 2022 |
| Pathogenetic and prognostic implications of increased mitochondrial content in multiple myeloma Y Ruiz-Heredia, A Ortiz-Ruiz, MK Samur, V Garrido, L Rufian, R Sanchez, ... Cancers 13 (13), 3189, 2021 | 6 | 2021 |
| The eµ-hnRNP K murine model of lymphoma: novel insights into the role of hnRNP K in b-cell malignancies P Malaney, M Velasco-Estevez, P Aguilar-Garrido, MJL Aitken, LE Chan, ... Frontiers in immunology 12, 634584, 2021 | 3 | 2021 |
| S104: RBPs dysregulation cause hyper-nucleoli and ribosome gain-of-function driving bone marrow failure P Aguilar-Garrido, M Velasco, MH Sánchez, MÁN Aguadero, P Malaney, ... HemaSphere 6, 5-6, 2022 | 1 | 2022 |
| Increase of Mitochondrial Activity Contributes to the Bortezomib-Relapsed in Multiple Myeloma, a Novel Therapeutic Opportunity A Ortiz-Ruiz, Y Ruiz-Heredia, M Samur, P Aguilar-Garrido, ML Morales, ... Blood 134, 4408, 2019 | 1 | 2019 |
| Cancer-Stem-Cell Phenotype-Guided Discovery of a Microbiota-Inspired Synthetic Compound Targeting NPM1 for Leukemia S Algar, H Vázquez-Villa, P Aguilar-Garrido, MÁ Navarro-Aguadero, ... JACS Au, 2024 | | 2024 |
| Hnrnpk Overexpression Drives Nucleolar Aberrancies Causing Ribosomopathies P Aguilar-Garrido, M Velasco-Estevez, MÁ Navarro-Aguadero, ... Blood 142, 5659, 2023 | | 2023 |
| S179: HNRNPK OVEREXPRESSION DRIVES NUCLEOLAR ABERRANCIES CAUSING RIBOSOMPATHIES PA Garrido, MV Estevez, MÁN Aguadero, MH Sánchez, P Malaney, ... HemaSphere 7, e8819188, 2023 | | 2023 |
| P846: GENERATION OF A FIRST-IN-CLASS INHIBITOR FOR THE MASTER ONCOREGULATOR HNRNP K IN HAEMATOLOGICAL MALIGNANCIES Á Otero-Sobrino, J Le Coq, P Aguilar-Garrido, MÁN Aguadero, ... HemaSphere 7 (S3), e16620e5, 2023 | | 2023 |
| The nucleolar aberrancies that drive ribosome impairment induced by RNA binding proteins are hallmarks of aging P Aguilar-Garrido, M Velasco-Estevez, MA Navarro-Aguadero, ... bioRxiv, 2023.03. 07.531270, 2023 | | 2023 |
| P863: GENERATION OF A FIRST-IN-CLASS INHIBITOR FOR THE MASTER ONCOREGULATOR HNRNP K IN MULTIPLE MYELOMA ÁO Sobrino, J Le Coq, P Aguilar-Garrido, MÁN Aguadero, MI Albarrán, ... HemaSphere 6 (Suppl), 2022 | | 2022 |
| P474: PIEZO1 AND THE THERAPEUTIC POTENTIAL OF MECHANORECEPTORS IN ACUTE MYELOID LEUKAEMIA MV Estevez, A Fernandez, A Otero-Sobrino, P Aguilar-Garrido, ... HemaSphere 6, 373-374, 2022 | | 2022 |
| PART 1: THE ROLE OF MECHANORECEPTION IN CELL DIFFERENTIATION AND ITS THERAPEUTIC POTENTIAL IN ACUTE MYELOID LEUKEMIA V Estevez Maria, A Garrido Pedro, NA Miguel Angel, G Vanessa, G Alicia, ... HAEMATOLOGICA 106 (10), 84-84, 2021 | | 2021 |
| A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia M Ramos, N Isasbel, M Balabasquer Peña, FJ Ortega Nogales, ... American chemical Society (ACS), 2019 | | 2019 |
